1 week Ago By ABMN Staff
Barclays PLC trimmed its position in Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
The fund owned 220,240 shares of the company’s stock after selling 3,778 shares during the quarter. Barclays PLC owned about 0.18% of Privia Health Group worth $4,305,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Virtu Financial LLC acquired a new position in shares of Privia Health Group during the third quarter valued at about $263,000. Franklin Resources Inc.
raised its position in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc.
now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares in the last quarter. JPMorgan Chase & Co. raised its position in Privia Health Group by 8.
4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after purchasing an additional 14,641 shares in the last quarter.
Nordea Investment Management AB raised its position in Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after purchasing an additional 86,910 shares in the last quarter.
Finally, Park Avenue Securities LLC raised its position in Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after purchasing an additional 532 shares in the last quarter.
94.48% of the stock is currently owned by institutional investors and hedge funds. Privia Health Group Trading Down 1.
2 % PRVA opened at $23.17 on Monday. The stock has a market capitalization of $2.
81 billion, a P/E ratio of 231.72, a P/E/G ratio of 3.47 and a beta of 0.
88. Privia Health Group, Inc. has a 12 month low of $15.
92 and a 12 month high of $26.04. The firm’s fifty day simple moving average is $23.
64 and its 200 day simple moving average is $21.94. Wall Street Analyst Weigh In View Our Latest Stock Report on Privia Health Group Insiders Place Their Bets In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction dated Wednesday, April 2nd.
The shares were sold at an average price of $22.38, for a total transaction of $125,999.40.
Following the sale, the chief financial officer now directly owns 179,676 shares of the company’s stock, valued at $4,021,148.88. The trade was a 3.
04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link . Insiders own 10.
70% of the company’s stock. Privia Health Group Company Profile ( Free Report ) Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Stories Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ).
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter ..
